Diagnostic gastroenterology

Freenome Presents Data Demonstrating the Importance of Clinical Test Performance and Screening Adherence on Colorectal Cancer Outcomes

Retrieved on: 
Friday, May 21, 2021
Software, Biotechnology, Oncology, General Health, Health, Technology, Clinical trials, Other Technology, Medicine, Clinical medicine, Medical diagnosis, Diagnostic gastroenterology, Cancer screening, Infectious causes of cancer, Colorectal cancer, Screening, Colonoscopy, the Posters, the PREEMPT CRC™ study, Freenome, THE POSTERS, THE PREEMPT CRC™ STUDY, FREENOME

This study suggests that earlier detection of colorectal neoplasia improves clinical outcomes and highlights the benefits of preventing CRC through adenoma detection and subsequent lifelong colonoscopy surveillance.\nThe second study emphasized the importance of screening test adherence and the time that elapses between screening tests (test interval) on clinical outcomes.

Key Points: 
  • This study suggests that earlier detection of colorectal neoplasia improves clinical outcomes and highlights the benefits of preventing CRC through adenoma detection and subsequent lifelong colonoscopy surveillance.\nThe second study emphasized the importance of screening test adherence and the time that elapses between screening tests (test interval) on clinical outcomes.
  • This study indicated that imperfect adherence mimics delays in screening, with both resulting in worse outcomes.
  • Freenome is also building a machine learning feedback loop with healthcare providers to leverage real-world data and improve patient care through early detection.
  • Freenome is headquartered in South San Francisco, California.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210521005112/en/\n'

Precision Optics Reports Third Quarter Fiscal Year 2021 Financial Results

Retrieved on: 
Thursday, May 13, 2021
Diagnostic gastroenterology, Endoscopy

A webcast replay will be available at https://www.webcaster4.com/Webcast/Page/2109/40924 .\nFounded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.

Key Points: 
  • A webcast replay will be available at https://www.webcaster4.com/Webcast/Page/2109/40924 .\nFounded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.
  • In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes.
  • These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management.
  • These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict.

Global Endoscopy Fluid Management Systems Market to 2026 - Insights, Competitive Landscape and Market Forecast - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 4, 2021
Health, General Health, Diagnostic gastroenterology, Endoscopy

b"To keep up with the market trends, we take KOLs and SME's opinion working in Endoscopy Fluid Management Systems domain through primary research to fill the data gaps and validate our secondary research.

Key Points: 
  • b"To keep up with the market trends, we take KOLs and SME's opinion working in Endoscopy Fluid Management Systems domain through primary research to fill the data gaps and validate our secondary research.
  • Their opinion helps to understand and validate current and emerging therapies treatment patterns or Endoscopy Fluid Management Systems market trend.
  • This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.\nThe report covers the descriptive overview of Endoscopy Fluid Management Systems, explaining its applications, advantages, and limitations, etc.\nAdditionally, an all-inclusive account of the currently available Endoscopy Fluid Management Systems is provided, which will have an impact on the future market of Endoscopy Fluid Management Systems.\nA detailed review of Endoscopy Fluid Management Systems market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.\nThe report provides an edge while developing business strategies, by understanding trends shaping and driving the Endoscopy Fluid Management Systems market.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210504005634/en/\n"

Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People

Retrieved on: 
Wednesday, April 28, 2021
Medicine, Clinical medicine, Branches of biology, Diagnostic gastroenterology, Cancer screening, Large intestine, Exact Sciences, Colonoscopy, Colorectal cancer, Screening, Cancer

The study showed the non-invasive Cologuard test had high sensitivity in detecting colorectal cancer and large pre-cancerous lesions making it a strong candidate for increasing the screening options available for AN people.5\n"My earlier research showed that Cologuard is an effective screening test in Alaska Native people," Redwood said.

Key Points: 
  • The study showed the non-invasive Cologuard test had high sensitivity in detecting colorectal cancer and large pre-cancerous lesions making it a strong candidate for increasing the screening options available for AN people.5\n"My earlier research showed that Cologuard is an effective screening test in Alaska Native people," Redwood said.
  • "\nEach strategy reduced costs and increased QALYs in comparison with no screening, with Cologuard outperforming FIT and colonoscopy screening in all adherence scenarios.
  • Cost-effectiveness of multitarget stool DNA testing vs colonoscopy or fecal immunochemical testing for colorectal cancer screening in Alaska Native people.
  • Cologuard performance in repeat testing has not been evaluated.\nThe Cologuard test result should be interpreted with caution.

Global Colonoscopy Devices Market Report 2021-2027 - Artificial Intelligence to Hold Instrumental Role in Timely Identification of Colorectal Cancer during Colonoscopy

Retrieved on: 
Tuesday, April 27, 2021
Clinical medicine, Medicine, Cancer screening, Gastroenterology, Diagnostic gastroenterology, Endoscopy, Large intestine, Colonoscopy, Colorectal cancer, Cancer

Endoscopy the mainstay for the diagnosis & management of colorectal cancer is coming under pressure as COVID-19 continues to spread.

Key Points: 
  • Endoscopy the mainstay for the diagnosis & management of colorectal cancer is coming under pressure as COVID-19 continues to spread.
  • The risk of contracting the infection in healthcare settings is discouraging people from screening and treatment for various conditions including cancer.
  • However, without timely screening, the scenario is anticipated to adversely impact cancer patients, leading to increase in colorectal cancer mortalities.
  • Colorectal cancer represents the largest application area for colonoscopy devices, driven by the rising prevalence of colorectal cancer globally.\nIn contrast to invasive surgeries, colonoscopy procedures do not require any incision, which is likely to significantly augment the demand for colonoscopy devices.

WELL Health Reports on CRH Medical's Upsized US$300M Revolving Credit Facility with JP Morgan

Retrieved on: 
Monday, April 26, 2021
Clinical medicine, Medicine, Medical specialties, Diagnostic gastroenterology, Colorectal surgery, Chromium(I) hydride, Endoscopy, Hemorrhoid, Surgery, Banding, Rubber band ligation

WELL is also a provider of digital health, billing and cybersecurity related technology solutions.

Key Points: 
  • WELL is also a provider of digital health, billing and cybersecurity related technology solutions.
  • In 2014, CRH became a full service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • In addition, CRH owns the "CRH O\'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.
  • Except as required by law, the Company does not intend to update these forward-looking statements.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/well-health-reports-on-crh-medic...\nSOURCE WELL Health Technologies Corp.\n'

PE GI Solutions Announces Partnership of Capital Digestive Care and Gastrointestinal & Liver Specialists of Tidewater (GLST)

Retrieved on: 
Thursday, April 22, 2021
Diagnostic gastroenterology, Endoscopy, Gastroenterology

The expansion comes with Capital Digestive Care\'s recent partnership with Gastrointestinal & Liver Specialists of Tidewater, PLLC (GLST), a leading gastroenterology practice in Southeastern Virginia.\nThe addition of GLST marks Capital Digestive Care\'s first partnership in Virginia and adds on eight practice locations within Southeastern Virginia, bringing Capital Digestive Care to 128 specialized GI providers serving the Mid-Atlantic Region.\nA key element of this partnership agreement is the value of leveraging the PE Practice Solutions platform under PE GI Solutions (formerly Physicians Endoscopy) a physician-oriented management services organization (MSO).

Key Points: 
  • The expansion comes with Capital Digestive Care\'s recent partnership with Gastrointestinal & Liver Specialists of Tidewater, PLLC (GLST), a leading gastroenterology practice in Southeastern Virginia.\nThe addition of GLST marks Capital Digestive Care\'s first partnership in Virginia and adds on eight practice locations within Southeastern Virginia, bringing Capital Digestive Care to 128 specialized GI providers serving the Mid-Atlantic Region.\nA key element of this partnership agreement is the value of leveraging the PE Practice Solutions platform under PE GI Solutions (formerly Physicians Endoscopy) a physician-oriented management services organization (MSO).
  • "We continue to provide support at all touchpoints of the GI patient care journey and remain focused on supporting Capital Digestive Care\'s efforts to provide best-in-class GI patient care and services.
  • For more information on PE GI Solutions, please visit www.pegisolutions.com .\nFounded in 2009, Capital Digestive Care is the largest private gastroenterology practice in the Mid-Atlantic.
  • For more information on Capital Digestive Care, please visit www.capitaldigestivecare.com .\nAbout Gastrointestinal & Liver Specialists of Tidewater, PLLC\nFor more than 25 years, Gastrointestinal & Liver Specialists of Tidewater, PLLC (GLST) has been the premier practice for liver and gastroenterology in Southeastern Virginia.

Happy Colon Foods Colonoscopy Food Kit Now Available in Kansas City, MO through Consultants in Gastroenterology, A Division of Digestive Health Specialists

Retrieved on: 
Tuesday, April 20, 2021
Clinical medicine, Medicine, Gastroenterology, Large intestine, Diagnostic gastroenterology, Cancer screening, Endoscopy, Organs, Colonoscopy, Colorectal cancer

b'KANSAS CITY, Mo., April 20, 2021 /PRNewswire-PRWeb/ -- Happy Colon Foods announces its availability in Kansas City, MO through a new, ongoing partnership with Consultants in Gastroenterology , a division of Digestive Health Specialists .

Key Points: 
  • b'KANSAS CITY, Mo., April 20, 2021 /PRNewswire-PRWeb/ -- Happy Colon Foods announces its availability in Kansas City, MO through a new, ongoing partnership with Consultants in Gastroenterology , a division of Digestive Health Specialists .
  • Happy Colon Foods is the only standardized kit of low-residue foods for use when prepping for a colonoscopy.\nHappy Colon Foods was created and developed by Board Certified Gastroenterologist, Jeff D. Scott, M.D.
  • Studies show that a low-residue diet, which is very easy for the body to process, will yield equal or better colonoscopy prep results than liquid preps.
  • "\nWith this new partnership, patients at Digestive Health Specialists will now have the opportunity to choose Happy Colon Foods when they need to prep for a colonoscopy.\nHappy Colon Foods offers the only standardized kit of low-residue foods for use when prepping for a colonoscopy.

Insights on the Veterinary Endoscopy Global Market to 2026 - Players Include Medtronic, Olympus and Steris Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, April 12, 2021
Veterinary, Health, Medicine, Clinical medicine, Medical specialties, Endoscopy, Diagnostic gastroenterology, Medical equipment, Biopsy, Endoscope, Speculum, Esophagogastroduodenoscopy

The most common flexible endoscopic procedures performed both in specialty and general practices are upper and lower GI endoscopy, for direct examination and biopsy of selected areas of the GI tract.

Key Points: 
  • The most common flexible endoscopic procedures performed both in specialty and general practices are upper and lower GI endoscopy, for direct examination and biopsy of selected areas of the GI tract.
  • Companies such as STERIS have experience in Endo-i Veterinary Endoscope repairs, which is one of the significant investments for veterinary practices.
  • Also, the growing pet population along with increasing spending on pet care is fueling the market's growth.
  • Hence, owing to the aforementioned factors, the studied market is expected to witness significant growth in North America over the forecast period.\n"

Outlook on the Fecal Occult Testing Global Market to 2026 - by Test Type, End-user and Region

Retrieved on: 
Tuesday, April 13, 2021
Diagnostic gastroenterology, Stool tests, Fecal occult blood, Occult blood, FOBT, Stool, Rectovaginal examination

b'DUBLIN, April 13, 2021 /PRNewswire/ -- The "Fecal Occult Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global fecal occult testing market grew at a CAGR of around 5% during 2015-2020.

Key Points: 
  • b'DUBLIN, April 13, 2021 /PRNewswire/ -- The "Fecal Occult Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global fecal occult testing market grew at a CAGR of around 5% during 2015-2020.
  • A fecal occult blood test (FOBT) is a noninvasive procedure used to detect hidden blood in the feces or stool.
  • It is performed by collecting samples using cards and flushable reagent pads or tissues.
  • Furthermore, the widespread adoption of minimally invasive (MI) procedures is contributing to the growth of the market.